nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP2C19—Rosuvastatin—atherosclerosis	0.133	0.195	CbGbCtD
Pentobarbital—CYP2C19—Simvastatin—atherosclerosis	0.123	0.181	CbGbCtD
Pentobarbital—CYP2C19—Lovastatin—atherosclerosis	0.121	0.177	CbGbCtD
Pentobarbital—CYP3A4—Rosuvastatin—atherosclerosis	0.0641	0.0941	CbGbCtD
Pentobarbital—CYP3A4—Ezetimibe—atherosclerosis	0.0641	0.0941	CbGbCtD
Pentobarbital—CYP3A4—Simvastatin—atherosclerosis	0.0596	0.0875	CbGbCtD
Pentobarbital—CYP3A4—Pravastatin—atherosclerosis	0.0583	0.0857	CbGbCtD
Pentobarbital—CYP3A4—Lovastatin—atherosclerosis	0.0583	0.0857	CbGbCtD
Pentobarbital—Nightmare—Rosuvastatin—atherosclerosis	0.00824	0.0421	CcSEcCtD
Pentobarbital—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00709	0.0362	CcSEcCtD
Pentobarbital—Hepatocellular injury—Simvastatin—atherosclerosis	0.00676	0.0346	CcSEcCtD
Pentobarbital—Nightmare—Simvastatin—atherosclerosis	0.00653	0.0334	CcSEcCtD
Pentobarbital—Hepatocellular injury—Pravastatin—atherosclerosis	0.00612	0.0312	CcSEcCtD
Pentobarbital—Nightmare—Pravastatin—atherosclerosis	0.0059	0.0302	CcSEcCtD
Pentobarbital—Angioedema—Rosuvastatin—atherosclerosis	0.00341	0.0174	CcSEcCtD
Pentobarbital—Confusional state—Rosuvastatin—atherosclerosis	0.00307	0.0157	CcSEcCtD
Pentobarbital—Angioedema—Lovastatin—atherosclerosis	0.00289	0.0148	CcSEcCtD
Pentobarbital—Angioedema—Ezetimibe—atherosclerosis	0.00283	0.0145	CcSEcCtD
Pentobarbital—Angioedema—Simvastatin—atherosclerosis	0.0027	0.0138	CcSEcCtD
Pentobarbital—Anxiety—Lovastatin—atherosclerosis	0.00268	0.0137	CcSEcCtD
Pentobarbital—Tension—Niacin—atherosclerosis	0.00266	0.0136	CcSEcCtD
Pentobarbital—Nervousness—Niacin—atherosclerosis	0.00264	0.0135	CcSEcCtD
Pentobarbital—Tension—Pravastatin—atherosclerosis	0.00262	0.0134	CcSEcCtD
Pentobarbital—Constipation—Rosuvastatin—atherosclerosis	0.0026	0.0133	CcSEcCtD
Pentobarbital—Confusional state—Lovastatin—atherosclerosis	0.0026	0.0133	CcSEcCtD
Pentobarbital—Nervousness—Pravastatin—atherosclerosis	0.0026	0.0133	CcSEcCtD
Pentobarbital—Confusional state—Ezetimibe—atherosclerosis	0.00255	0.013	CcSEcCtD
Pentobarbital—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00251	0.0128	CcSEcCtD
Pentobarbital—Anxiety—Simvastatin—atherosclerosis	0.00251	0.0128	CcSEcCtD
Pentobarbital—Angioedema—Niacin—atherosclerosis	0.00248	0.0127	CcSEcCtD
Pentobarbital—Angioedema—Pravastatin—atherosclerosis	0.00244	0.0125	CcSEcCtD
Pentobarbital—Syncope—Niacin—atherosclerosis	0.00243	0.0124	CcSEcCtD
Pentobarbital—Confusional state—Simvastatin—atherosclerosis	0.00243	0.0124	CcSEcCtD
Pentobarbital—Loss of consciousness—Niacin—atherosclerosis	0.00239	0.0122	CcSEcCtD
Pentobarbital—Anxiety—Pravastatin—atherosclerosis	0.00227	0.0116	CcSEcCtD
Pentobarbital—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00224	0.0115	CcSEcCtD
Pentobarbital—Constipation—Lovastatin—atherosclerosis	0.00221	0.0113	CcSEcCtD
Pentobarbital—Confusional state—Pravastatin—atherosclerosis	0.0022	0.0112	CcSEcCtD
Pentobarbital—Shock—Niacin—atherosclerosis	0.00218	0.0111	CcSEcCtD
Pentobarbital—Constipation—Ezetimibe—atherosclerosis	0.00216	0.0111	CcSEcCtD
Pentobarbital—Feeling abnormal—Lovastatin—atherosclerosis	0.00213	0.0109	CcSEcCtD
Pentobarbital—Feeling abnormal—Ezetimibe—atherosclerosis	0.00209	0.0107	CcSEcCtD
Pentobarbital—Hypotension—Niacin—atherosclerosis	0.00207	0.0106	CcSEcCtD
Pentobarbital—Constipation—Simvastatin—atherosclerosis	0.00206	0.0105	CcSEcCtD
Pentobarbital—Body temperature increased—Lovastatin—atherosclerosis	0.00204	0.0104	CcSEcCtD
Pentobarbital—Dizziness—Rosuvastatin—atherosclerosis	0.00201	0.0103	CcSEcCtD
Pentobarbital—Body temperature increased—Ezetimibe—atherosclerosis	0.002	0.0102	CcSEcCtD
Pentobarbital—Feeling abnormal—Simvastatin—atherosclerosis	0.00199	0.0102	CcSEcCtD
Pentobarbital—Somnolence—Niacin—atherosclerosis	0.00197	0.0101	CcSEcCtD
Pentobarbital—Rash—Rosuvastatin—atherosclerosis	0.00192	0.00981	CcSEcCtD
Pentobarbital—Dermatitis—Rosuvastatin—atherosclerosis	0.00192	0.0098	CcSEcCtD
Pentobarbital—Body temperature increased—Simvastatin—atherosclerosis	0.00191	0.00975	CcSEcCtD
Pentobarbital—Headache—Rosuvastatin—atherosclerosis	0.00191	0.00974	CcSEcCtD
Pentobarbital—Hypersensitivity—Lovastatin—atherosclerosis	0.0019	0.00971	CcSEcCtD
Pentobarbital—Constipation—Pravastatin—atherosclerosis	0.00187	0.00953	CcSEcCtD
Pentobarbital—Hypersensitivity—Ezetimibe—atherosclerosis	0.00186	0.00952	CcSEcCtD
Pentobarbital—Nausea—Rosuvastatin—atherosclerosis	0.00181	0.00924	CcSEcCtD
Pentobarbital—Feeling abnormal—Pravastatin—atherosclerosis	0.0018	0.00918	CcSEcCtD
Pentobarbital—Hypersensitivity—Simvastatin—atherosclerosis	0.00178	0.00908	CcSEcCtD
Pentobarbital—Body temperature increased—Niacin—atherosclerosis	0.00175	0.00895	CcSEcCtD
Pentobarbital—Body temperature increased—Pravastatin—atherosclerosis	0.00172	0.00881	CcSEcCtD
Pentobarbital—Dizziness—Lovastatin—atherosclerosis	0.00171	0.00872	CcSEcCtD
Pentobarbital—Dizziness—Ezetimibe—atherosclerosis	0.00167	0.00855	CcSEcCtD
Pentobarbital—Vomiting—Lovastatin—atherosclerosis	0.00164	0.00838	CcSEcCtD
Pentobarbital—Hypersensitivity—Niacin—atherosclerosis	0.00163	0.00834	CcSEcCtD
Pentobarbital—Rash—Lovastatin—atherosclerosis	0.00163	0.00831	CcSEcCtD
Pentobarbital—Dermatitis—Lovastatin—atherosclerosis	0.00163	0.0083	CcSEcCtD
Pentobarbital—Headache—Lovastatin—atherosclerosis	0.00162	0.00826	CcSEcCtD
Pentobarbital—Vomiting—Ezetimibe—atherosclerosis	0.00161	0.00822	CcSEcCtD
Pentobarbital—Hypersensitivity—Pravastatin—atherosclerosis	0.00161	0.00821	CcSEcCtD
Pentobarbital—Dizziness—Simvastatin—atherosclerosis	0.0016	0.00815	CcSEcCtD
Pentobarbital—Rash—Ezetimibe—atherosclerosis	0.0016	0.00815	CcSEcCtD
Pentobarbital—Dermatitis—Ezetimibe—atherosclerosis	0.00159	0.00814	CcSEcCtD
Pentobarbital—Headache—Ezetimibe—atherosclerosis	0.00159	0.0081	CcSEcCtD
Pentobarbital—Vomiting—Simvastatin—atherosclerosis	0.00153	0.00784	CcSEcCtD
Pentobarbital—Nausea—Lovastatin—atherosclerosis	0.00153	0.00783	CcSEcCtD
Pentobarbital—Rash—Simvastatin—atherosclerosis	0.00152	0.00777	CcSEcCtD
Pentobarbital—Dermatitis—Simvastatin—atherosclerosis	0.00152	0.00777	CcSEcCtD
Pentobarbital—Headache—Simvastatin—atherosclerosis	0.00151	0.00772	CcSEcCtD
Pentobarbital—Nausea—Ezetimibe—atherosclerosis	0.0015	0.00768	CcSEcCtD
Pentobarbital—Dizziness—Niacin—atherosclerosis	0.00147	0.00749	CcSEcCtD
Pentobarbital—Dizziness—Pravastatin—atherosclerosis	0.00144	0.00737	CcSEcCtD
Pentobarbital—Nausea—Simvastatin—atherosclerosis	0.00143	0.00732	CcSEcCtD
Pentobarbital—Vomiting—Niacin—atherosclerosis	0.00141	0.0072	CcSEcCtD
Pentobarbital—Rash—Niacin—atherosclerosis	0.0014	0.00714	CcSEcCtD
Pentobarbital—Dermatitis—Niacin—atherosclerosis	0.0014	0.00713	CcSEcCtD
Pentobarbital—Headache—Niacin—atherosclerosis	0.00139	0.00709	CcSEcCtD
Pentobarbital—Vomiting—Pravastatin—atherosclerosis	0.00139	0.00709	CcSEcCtD
Pentobarbital—Rash—Pravastatin—atherosclerosis	0.00138	0.00703	CcSEcCtD
Pentobarbital—Dermatitis—Pravastatin—atherosclerosis	0.00137	0.00702	CcSEcCtD
Pentobarbital—Headache—Pravastatin—atherosclerosis	0.00137	0.00698	CcSEcCtD
Pentobarbital—Nausea—Niacin—atherosclerosis	0.00132	0.00672	CcSEcCtD
Pentobarbital—Nausea—Pravastatin—atherosclerosis	0.0013	0.00662	CcSEcCtD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000114	0.000924	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—STAT3—atherosclerosis	0.000114	0.000923	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000113	0.00092	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000113	0.000916	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000112	0.00091	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000112	0.000908	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.00011	0.000893	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000109	0.000887	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000109	0.000886	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—MAPK3—atherosclerosis	0.000109	0.000882	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PLTP—atherosclerosis	0.000108	0.000879	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—AKT1—atherosclerosis	0.000105	0.000851	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000105	0.000849	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000103	0.000839	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000103	0.000838	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000102	0.000831	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000102	0.000827	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000102	0.000824	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—APOB—atherosclerosis	0.0001	0.000813	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—PLG—atherosclerosis	9.95e-05	0.000807	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTM1—atherosclerosis	9.91e-05	0.000804	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—APOB—atherosclerosis	9.9e-05	0.000803	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTM1—atherosclerosis	9.78e-05	0.000793	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—PLG—atherosclerosis	9.77e-05	0.000792	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—PLAT—atherosclerosis	9.63e-05	0.000781	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—PLG—atherosclerosis	9.6e-05	0.000779	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	9.56e-05	0.000775	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	9.56e-05	0.000775	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—PLG—atherosclerosis	9.54e-05	0.000774	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	9.45e-05	0.000766	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCG8—atherosclerosis	9.4e-05	0.000762	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LTA4H—atherosclerosis	9.4e-05	0.000762	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	9.38e-05	0.000761	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—PLG—atherosclerosis	9.37e-05	0.00076	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	9.26e-05	0.000751	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	9.22e-05	0.000747	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—atherosclerosis	9.18e-05	0.000745	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—APOB—atherosclerosis	9.06e-05	0.000734	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	9.02e-05	0.000731	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	8.86e-05	0.000719	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	8.81e-05	0.000714	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—APOB—atherosclerosis	8.8e-05	0.000713	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	8.65e-05	0.000701	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—APOB—atherosclerosis	8.64e-05	0.0007	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	8.52e-05	0.000691	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—APOB—atherosclerosis	8.49e-05	0.000688	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—PPARA—atherosclerosis	8.46e-05	0.000686	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—APOB—atherosclerosis	8.43e-05	0.000684	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—PPARA—atherosclerosis	8.35e-05	0.000677	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—APOB—atherosclerosis	8.28e-05	0.000672	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—PLG—atherosclerosis	8.19e-05	0.000664	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	8.08e-05	0.000655	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	8.08e-05	0.000655	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	8.08e-05	0.000655	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	8.08e-05	0.000655	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	7.98e-05	0.000647	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—atherosclerosis	7.94e-05	0.000644	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.93e-05	0.000643	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.83e-05	0.000635	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	7.71e-05	0.000625	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.64e-05	0.000619	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	7.56e-05	0.000613	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—TGFB1—atherosclerosis	7.55e-05	0.000612	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCG1—atherosclerosis	7.43e-05	0.000602	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.42e-05	0.000602	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	7.39e-05	0.000599	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—AKT1—atherosclerosis	7.34e-05	0.000595	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.29e-05	0.000591	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—APOB—atherosclerosis	7.24e-05	0.000587	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.16e-05	0.000581	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.16e-05	0.000581	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.11e-05	0.000577	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	7.11e-05	0.000577	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LDLRAP1—atherosclerosis	7.03e-05	0.00057	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—PPARA—atherosclerosis	6.99e-05	0.000566	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LCAT—atherosclerosis	6.98e-05	0.000566	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—FABP4—atherosclerosis	6.98e-05	0.000566	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.96e-05	0.000564	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	6.87e-05	0.000557	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOA4—atherosclerosis	6.85e-05	0.000556	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.84e-05	0.000554	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP7A1—atherosclerosis	6.73e-05	0.000546	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.72e-05	0.000545	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.67e-05	0.000541	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PLTP—atherosclerosis	6.61e-05	0.000536	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.55e-05	0.000531	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—atherosclerosis	6.41e-05	0.000519	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ALB—atherosclerosis	6.29e-05	0.00051	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP27A1—atherosclerosis	6.22e-05	0.000505	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ALB—atherosclerosis	6.21e-05	0.000503	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	6.12e-05	0.000496	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—PPARA—atherosclerosis	6.11e-05	0.000495	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	6.08e-05	0.000493	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	6.05e-05	0.00049	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	5.96e-05	0.000483	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	5.91e-05	0.000479	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOA2—atherosclerosis	5.9e-05	0.000478	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALOX15—atherosclerosis	5.9e-05	0.000478	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PLA2G2A—atherosclerosis	5.9e-05	0.000478	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALOX5AP—atherosclerosis	5.9e-05	0.000478	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	5.88e-05	0.000477	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCG5—atherosclerosis	5.83e-05	0.000473	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCG8—atherosclerosis	5.73e-05	0.000464	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LTA4H—atherosclerosis	5.73e-05	0.000464	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.73e-05	0.000464	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ALB—atherosclerosis	5.68e-05	0.00046	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	5.66e-05	0.000459	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LPA—atherosclerosis	5.63e-05	0.000456	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ALB—atherosclerosis	5.51e-05	0.000447	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—BGN—atherosclerosis	5.45e-05	0.000442	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ALB—atherosclerosis	5.42e-05	0.000439	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOA5—atherosclerosis	5.4e-05	0.000438	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	5.34e-05	0.000433	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ALB—atherosclerosis	5.32e-05	0.000431	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ALB—atherosclerosis	5.29e-05	0.000429	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PLA2G1B—atherosclerosis	5.19e-05	0.000421	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ALB—atherosclerosis	5.19e-05	0.000421	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALOX5—atherosclerosis	5.02e-05	0.000407	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.76e-05	0.000386	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ALB—atherosclerosis	4.54e-05	0.000368	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCG1—atherosclerosis	4.53e-05	0.000367	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NAMPT—atherosclerosis	4.5e-05	0.000365	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LIPC—atherosclerosis	4.47e-05	0.000363	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOC3—atherosclerosis	4.44e-05	0.00036	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LDLR—atherosclerosis	4.42e-05	0.000358	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CETP—atherosclerosis	4.31e-05	0.00035	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LCAT—atherosclerosis	4.26e-05	0.000345	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—FABP4—atherosclerosis	4.26e-05	0.000345	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	4.23e-05	0.000343	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOA4—atherosclerosis	4.18e-05	0.000339	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SCARB1—atherosclerosis	4.13e-05	0.000335	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP7A1—atherosclerosis	4.11e-05	0.000333	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PLTP—atherosclerosis	3.97e-05	0.000322	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.91e-05	0.000317	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HMGCR—atherosclerosis	3.9e-05	0.000316	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP27A1—atherosclerosis	3.79e-05	0.000308	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.74e-05	0.000303	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.64e-05	0.000296	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOA2—atherosclerosis	3.6e-05	0.000292	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	3.6e-05	0.000292	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALOX15—atherosclerosis	3.6e-05	0.000292	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	3.6e-05	0.000292	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCG5—atherosclerosis	3.55e-05	0.000288	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.55e-05	0.000288	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCA1—atherosclerosis	3.48e-05	0.000282	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LTA4H—atherosclerosis	3.44e-05	0.000279	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCG8—atherosclerosis	3.44e-05	0.000279	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LPA—atherosclerosis	3.43e-05	0.000278	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—BGN—atherosclerosis	3.32e-05	0.000269	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.3e-05	0.000268	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOA5—atherosclerosis	3.29e-05	0.000267	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.2e-05	0.000259	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	3.17e-05	0.000257	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.13e-05	0.000254	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.1e-05	0.000252	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.1e-05	0.000251	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALOX5—atherosclerosis	3.06e-05	0.000248	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HMOX1—atherosclerosis	2.98e-05	0.000242	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOB—atherosclerosis	2.86e-05	0.000232	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.83e-05	0.000229	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM1—atherosclerosis	2.78e-05	0.000225	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NAMPT—atherosclerosis	2.74e-05	0.000222	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LPL—atherosclerosis	2.73e-05	0.000221	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.73e-05	0.000221	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LIPC—atherosclerosis	2.73e-05	0.000221	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.72e-05	0.000221	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOC3—atherosclerosis	2.71e-05	0.00022	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LDLR—atherosclerosis	2.69e-05	0.000218	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GPX1—atherosclerosis	2.66e-05	0.000216	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CETP—atherosclerosis	2.63e-05	0.000213	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CD36—atherosclerosis	2.59e-05	0.00021	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LCAT—atherosclerosis	2.56e-05	0.000208	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—FABP4—atherosclerosis	2.56e-05	0.000208	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SCARB1—atherosclerosis	2.52e-05	0.000204	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOA4—atherosclerosis	2.51e-05	0.000204	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.47e-05	0.0002	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTHFR—atherosclerosis	2.46e-05	0.000199	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.45e-05	0.000199	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPARA—atherosclerosis	2.41e-05	0.000195	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HMGCR—atherosclerosis	2.38e-05	0.000193	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AGT—atherosclerosis	2.33e-05	0.000189	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOE—atherosclerosis	2.29e-05	0.000185	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.28e-05	0.000185	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CAV1—atherosclerosis	2.27e-05	0.000184	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOA1—atherosclerosis	2.26e-05	0.000183	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOA2—atherosclerosis	2.16e-05	0.000175	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.16e-05	0.000175	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.16e-05	0.000175	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.16e-05	0.000175	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.15e-05	0.000174	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.14e-05	0.000173	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCA1—atherosclerosis	2.12e-05	0.000172	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CG—atherosclerosis	2.06e-05	0.000167	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LPA—atherosclerosis	2.06e-05	0.000167	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—BGN—atherosclerosis	2e-05	0.000162	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPARG—atherosclerosis	1.99e-05	0.000162	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOA5—atherosclerosis	1.98e-05	0.00016	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—INS—atherosclerosis	1.95e-05	0.000158	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.9e-05	0.000154	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.84e-05	0.000149	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.82e-05	0.000147	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALB—atherosclerosis	1.79e-05	0.000145	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOB—atherosclerosis	1.74e-05	0.000141	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NOS3—atherosclerosis	1.71e-05	0.000139	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.69e-05	0.000137	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LPL—atherosclerosis	1.66e-05	0.000135	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.65e-05	0.000134	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LIPC—atherosclerosis	1.64e-05	0.000133	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOC3—atherosclerosis	1.63e-05	0.000132	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPX1—atherosclerosis	1.62e-05	0.000132	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LDLR—atherosclerosis	1.62e-05	0.000131	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CETP—atherosclerosis	1.58e-05	0.000128	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CD36—atherosclerosis	1.58e-05	0.000128	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTGS2—atherosclerosis	1.57e-05	0.000127	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.51e-05	0.000123	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.5e-05	0.000121	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPARA—atherosclerosis	1.47e-05	0.000119	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.43e-05	0.000116	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AGT—atherosclerosis	1.42e-05	0.000115	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOE—atherosclerosis	1.39e-05	0.000113	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CAV1—atherosclerosis	1.38e-05	0.000112	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOA1—atherosclerosis	1.38e-05	0.000112	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.27e-05	0.000103	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.26e-05	0.000102	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPARG—atherosclerosis	1.21e-05	9.85e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—INS—atherosclerosis	1.19e-05	9.66e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.09e-05	8.87e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALB—atherosclerosis	1.09e-05	8.86e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOB—atherosclerosis	1.05e-05	8.5e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NOS3—atherosclerosis	1.04e-05	8.47e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.02e-05	8.26e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LPL—atherosclerosis	1e-05	8.11e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPX1—atherosclerosis	9.76e-06	7.91e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTGS2—atherosclerosis	9.56e-06	7.75e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CD36—atherosclerosis	9.51e-06	7.71e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTHFR—atherosclerosis	9.01e-06	7.3e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPARA—atherosclerosis	8.84e-06	7.17e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AGT—atherosclerosis	8.56e-06	6.94e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOE—atherosclerosis	8.39e-06	6.8e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CAV1—atherosclerosis	8.31e-06	6.74e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOA1—atherosclerosis	8.29e-06	6.72e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AKT1—atherosclerosis	7.88e-06	6.39e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CG—atherosclerosis	7.57e-06	6.14e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPARG—atherosclerosis	7.3e-06	5.92e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—INS—atherosclerosis	7.16e-06	5.81e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALB—atherosclerosis	6.57e-06	5.33e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NOS3—atherosclerosis	6.28e-06	5.09e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTGS2—atherosclerosis	5.75e-06	4.66e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AKT1—atherosclerosis	4.8e-06	3.89e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AKT1—atherosclerosis	2.89e-06	2.34e-05	CbGpPWpGaD
